Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126268211 | 12626821 | 1 | I | 20160727 | 20160805 | 20160805 | EXP | IE-MYLANLABS-2016M1031990 | MYLAN | MEDANI SM, WALL C. COLCHICINE TOXICITY IN RENAL PATIENTS - ARE WE PAYING ATTENTION. CLINICAL NEPHROLOGY. 2016;86:100-105 | 0.00 | Y | 0.00000 | 20160805 | MD | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126268211 | 12626821 | 1 | PS | SIMVASTATIN MYLAN | SIMVASTATIN | 1 | UNK | U | U | 90868 | |||||||||
| 126268211 | 12626821 | 2 | SS | COLCHICINE. | COLCHICINE | 1 | 0.5 MG, TID | U | U | 0 | .5 | MG | TID | ||||||
| 126268211 | 12626821 | 3 | C | GLICLAZIDE | GLICLAZIDE | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 4 | C | VALSARTAN. | VALSARTAN | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 6 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 7 | C | FRUSEMIDE /00032601/ | FUROSEMIDE | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 9 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | U | 0 | ||||||||||
| 126268211 | 12626821 | 10 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126268211 | 12626821 | 1 | Product used for unknown indication |
| 126268211 | 12626821 | 2 | Gout |
| 126268211 | 12626821 | 3 | Product used for unknown indication |
| 126268211 | 12626821 | 4 | Product used for unknown indication |
| 126268211 | 12626821 | 5 | Product used for unknown indication |
| 126268211 | 12626821 | 6 | Product used for unknown indication |
| 126268211 | 12626821 | 7 | Product used for unknown indication |
| 126268211 | 12626821 | 8 | Product used for unknown indication |
| 126268211 | 12626821 | 9 | Product used for unknown indication |
| 126268211 | 12626821 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126268211 | 12626821 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126268211 | 12626821 | Acute kidney injury | |
| 126268211 | 12626821 | Decreased appetite | |
| 126268211 | 12626821 | Diarrhoea | |
| 126268211 | 12626821 | Drug interaction | |
| 126268211 | 12626821 | Fall | |
| 126268211 | 12626821 | Muscular weakness | |
| 126268211 | 12626821 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |